Strolll has raised $5.8M in a Series A round, a bet that augmented reality can do more than entertain-it can rehabilitate. The funding comes from Innovate UK and IW Capital, backing the company’s push to turn AR glasses into a clinical tool for movement therapy.
Strolll builds Digital Therapeutics software that runs on AR headsets, guiding patients with neurological disorders through exercises designed to improve motor function. The idea is to make rehab more engaging and measurable, replacing some traditional physiotherapy routines with interactive, real-time feedback. With this capital, the company is positioned to scale its platform, though specifics on product rollout or regulatory milestones weren’t disclosed.


















